Introduction {#section1-0394632017716370}
============

Tobacco smoke is a complex mixture of thousands of different chemicals, many of which have immunotoxicity.^[@bibr1-0394632017716370]^ Many constituents of cigarette smoke not only modulate the function of immune cells in vitro and/or after in vivo administration^[@bibr2-0394632017716370]^ but also impact the immunomodulatory response in a variety of experimental animal models and humans.^[@bibr3-0394632017716370]^ Increasing evidence has demonstrated that the effects of cigarette smoke on the immune system may reflect the cumulative effects of both immunosuppressive and immunostimulatory components in cigarette smoke. Cytokines are small molecules with large roles in modulating immune reactions. Macrophages may be activated by cigarette smoke condensate (CSC) to release inflammatory mediators. Several studies have shown that cigarette smoking is associated with mitogenic responses in lung lymphocytes and the production of interleukin (IL)-1β, IL-6, and tumor necrosis factor α (TNF-α) by peripheral blood mononuclear cells (PBMCs) and macrophages.^[@bibr4-0394632017716370]^ Macrophages play an important role in all organisms and are essential mediators of the immune system that contribute to inflammation and regulate tissue homeostasis.^[@bibr5-0394632017716370]^ As one type of mouse macrophages, the Ana-1 cell line has been used to assess toxicological effects due to cigarette smoke.^[@bibr6-0394632017716370]^ Macrophages play a major role in releasing cytokines, which regulate innate, adaptive immunity, cell growth, and tissue destruction.

The aim of this study was to investigate the general characteristics of the immunomodulatory effects of CSC. We selected the Ana-1 cell line and used Luminex technology to assess the release of 20 cytokines (IL-1a, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12, IL-13, IL-17, granulocyte-macrophage colony-stimulating factor (GM-CSF), interferon-γ (IFN-γ), keratinocyte-derived chemokine (KC), monocyte chemoattractant protein 1 (MCP-1), macrophage inflammatory protein 1α (MIP-1α), induced protein 10 (IP-10), TNF-α, vascular endothelial growth factor (VEGF), monkine inducible by γ interferon (MIG), and fibroblast growth factor (FGF)-basic) from macrophages stimulated with CSC from 12 brands of cigarettes.

Materials and methods {#section2-0394632017716370}
=====================

Reagents and equipment {#section3-0394632017716370}
----------------------

Ana-1 is a macrophage cell line, isolated from mouse thymus, obtained from the Cell Bank of the Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (China). RPMI 1640 culture medium and fetal bovine serum (FBS) were purchased from Gibco Co. Ltd (USA). The Cell Counting Kit-8 (CCK-8) was purchased from the Tokyo Institute of Japan. The Mouse Cytokine 20-Plex Panel was purchased from Life Technologies (USA). A high-speed centrifuge was purchased from Thermo Fisher Scientific (USA). A Bio-Plex Liqui Chip was purchased from Bio-Bad (USA), and 96-well plates were purchased from Corning Costar (USA). RM-20H smoking machine was purchased from Borgwaldt KC (Germany). Fully humidified incubator was purchased from Thermo Fisher Scientific (Germany). The 12 brands of cigarettes used are shown in [Table 1](#table1-0394632017716370){ref-type="table"}.

###### 

Characteristics of study samples.

![](10.1177_0394632017716370-table1)

  Brand   Type                     Specificity   Origin        
  ------- ------------------------ ------------- -------- ---- ---------------------------
  C1      Blended-type cigarette   9             0.7      11   Anhui Province, China
  C2      Flue-cured cigarette     12            1.1      12   Yunnan Province, China
  C3      Flue-cured cigarette     10            1.0      13   Hunan Province, China
  C4      Flue-cured cigarette     11            1.1      13   Hubei Province, China
  C5      Flue-cured cigarette     10            1.0      11   Henan Province, China
  C6      Blended-type cigarette   7             1.0      9    Fujian Province, China
  C7      Flue-cured cigarette     11            1.0      11   Zhejiang Province, China
  C8      Flue-cured cigarette     6             0.6      8    Fujian Province, China
  C9      Blended-type cigarette   11            1.0      12   Guangdong Province, China
  C10     Flue-cured cigarette     8             0.8      9    Yunnan Province, China
  C11     Flue-cured cigarette     8             0.8      10   Jilin Province, China
  C12     Blended-type cigarette   8             0.7      10   Beijing, China

Label of cigarette case.

Preparation of CSC {#section4-0394632017716370}
------------------

Cigarettes of 12 brands were conditioned unpacked in open containers following ISO standards^[@bibr7-0394632017716370]^ (at least 48 h at target conditions of 22°C ± 1°C and a relative humidity of 60% ± 3%). Borgwaldt RM-20H smoking machine was used to collect cigarette smoke. Total particulate matter was collected on glass fiber filters extracted with dimethyl sulfoxide (DMSO) followed by sterile filtration and then stored at −70°C.

Cell culture {#section5-0394632017716370}
------------

Ana-1 cells were cultured in RPMI 1640 medium, which was supplemented with 10% FBS, 100 units/mL penicillin, and 100 mg/mL streptomycin at 37°C in a fully humidified incubator containing 5% CO~2~.

Cell inhibition assay {#section6-0394632017716370}
---------------------

The exposure experiment of Ana-1 cells to CSC with the concentrations of 0, 12.5, 25, 50, 100, and 200 µg/mL was conducted. Cell viability was measured by CCK-8 assay. Each sample was assayed in sixtuplicate, and the values were expressed as mean of six experiments. Next, 2 × 10^5^ cells/well were seeded into a 96-well culture plate at a final volume of 200 µL. After 24 h of treatment, 10 µL of CCK-8 was added into each well and incubated for 90 min at 37°C in a 5% CO~2~ incubator. The absorbance at 490 nm was measured using a microplate reader. The inhibition rate was calculated using the following equation: Inhibition rate = \[(experimental group − blank group)/(control group − blank group)\] × 100%. An inhibition curve was plotted based on the CSC concentration and the inhibition rate. The concentrations of CSC selected (cell viability is more than 80%) were used for testing cytokines in this study.^[@bibr8-0394632017716370]^

Detection of cytokines after treatment with CSC {#section7-0394632017716370}
-----------------------------------------------

Detection of cytokines of CSC treated with the concentrations of 0, 2.5, 5, 10, and 20 µg/mL was assessed. The assay was performed in five replicates for each group. Next, 2 × 10^5^ cells/well were seeded into a 96-well culture plate to a final volume of 200 µL. After 24 h of treatment, cells were centrifuged at 1000 *g* for 10 min and then cell-free supernatants were recovered and stored at −80°C for subsequent analysis. All assays were performed according to the Mouse Cytokine 20-Plex Panel kit instructions. Median fluorescence intensities were collected on a Luminex-100 instrument using Bio-Plex Manager software version 6. Standard curves for each cytokine were generated using the premixed lyophilized standards provided in the kits. Cytokine concentrations in samples were determined from the appropriate standard curve. Each sample was run the five replicates, and the average of these replicates was used as the present data.

Statistical analyses {#section8-0394632017716370}
--------------------

The results are shown as the mean of the observed concentration of cytokines for CSC. A statistical analysis of the results was performed, and the statistical significance of the differences was tested using Fisher's test. Differences between groups were considered significant at *P* \< 0.05, and the actual *P* values are indicated for each series of experiments. A complete statistical analysis of the data was conducted with the statistical software package, SPSS Statistics 19.0 (IBM, USA).

Results {#section9-0394632017716370}
=======

Effect of CSC exposure on viability {#section10-0394632017716370}
-----------------------------------

CSC differentially induced cytotoxicity and reduced cell viability in a concentration-dependent manner in the macrophage cell line Ana-1, as measured by CCK-8 assay. For 12 brands of CSC, CCK-8 assay indicated that the number of Ana-1 cells in the CSC-treated group was lower than that of the control group (*P* \< 0.05). CSC significantly inhibited the proliferation of Ana-1 cells after 24 h of treatment. The data are shown in [Figure 1](#fig1-0394632017716370){ref-type="fig"}.

![The results show cell viability after exposure for 24 h to CSC from 12 brands (n = 6) as the mean ± standard deviation.](10.1177_0394632017716370-fig1){#fig1-0394632017716370}

Levels of cytokines after exposure to CSC from 12 brands of cigarette {#section11-0394632017716370}
---------------------------------------------------------------------

Compared with control ([Table 2](#table2-0394632017716370){ref-type="table"}), the release of IL-5, IL-6, IL-12, TNF-α, IP-10, MCP-1, MIP-1α, and VEGF (expect C10) ([Table 3](#table3-0394632017716370){ref-type="table"}) was significantly different for all 12 brands of cigarettes (*P* \< 0.05). However, there was no significant difference between some cytokines (IL-1α, IL-1β, IL-2, IL-4, IL-10, IL-13, IL-17, GM-CSF, IFN-γ, KC, MIG, and FGF-basic) and control (*P* \> 0.05) ([Table 2](#table2-0394632017716370){ref-type="table"}).

###### 

Release of 20 cytokines for the control (non-stimulated macrophages).

![](10.1177_0394632017716370-table2)

  Cytokine    Release level (mean ± SD) (pg/mL)
  ----------- -----------------------------------
  FGF-basic   192.47 ± 8.20
  GM-CSF      23.98 ± 1.40
  IFN-γ       25.18 ± 2.14
  IL-1α       36.49 ± 1.96
  IL-1β       91.78 ± 6.98
  IL-2        33.75 ± 2.37
  IL-4        240.59 ± 18.23
  IL-5        1092.68 ± 106.58
  IL-6        5137.66 ± 257.06
  IL-10       1297.45 ± 84.43
  IL-12       173.01 ± 16.31
  IL-13       108.56 ± 9.36
  IL-17       7.56 ± 0.64
  IP-10       3332.97 ± 678.80
  KC          1004.74 ± 41.33
  MCP-1       3498.78 ± 466.58
  MIG         361.47 ± 21.89
  MIP-1α      54,242.08 ± 8325.12
  TNF-α       2028.48 ± 464.00
  VEGF        1995.03 ± 252.24

SD: standard deviation; FGF: fibroblast growth factor; GM-CSF: granulocyte-macrophage colony-stimulating factor; IL: interleukin; IP-10: induced protein 10; VEGF: vascular endothelial growth factor; MCP-1: monocyte chemoattractant protein 1; MIP-1α) macrophage inflammatory protein 1α; TNF-α: tumor necrosis factor α; IFN-γ: interferon-γ.

###### 

Cytokine profiling of lower limits of detection with CSC exposure.

![](10.1177_0394632017716370-table3)

  Cigarette samples   Biologic function       Cytokine   Lower limit of detection (µg/mL CSC)   Release level (mean ± SD) (pg/mL)   *P* value
  ------------------- ----------------------- ---------- -------------------------------------- ----------------------------------- -----------
  C1                  Interleukins            IL-5       10                                     1049.07 ± 8.62                      0.045
                                              IL-6       2.5                                    4958.46 ± 243.25                    0.013
                                              IL-12      5                                      178.87 ± 3.14                       0.006
                      Chemokines              IP-10      2.5                                    4003.55 ± 450.70                    \<0.001
                                              MCP-1      2.5                                    3091.60 ± 281.95                    0.004
                                              MIP-1α     20                                     5346.08 ± 1496.87                   \<0.001
                      Growth factors          VEGF       5                                      2114.88 ± 88.70                     0.005
                      Tumor necrosis factor   TNF-α      5                                      2076.27 ± 59.73                     \<0.001
  C2                  Interleukins            IL-5       10                                     999.75 ± 54.01                      \<0.001
                                              IL-6       2.5                                    3910.23 ± 311.79                    0.001
                                              IL-12      10                                     144.21 ± 9.30                       0.003
                      Chemokines              IP-10      2.5                                    3896.13 ± 575.93                    \<0.001
                                              MCP-1      2.5                                    3020.66 ± 118.96                    0.006
                                              MIP-1α     20                                     8186.74 ± 1945.78                   \<0.001
                      Growth factors          VEGF       20                                     1402.73 ± 47.66                     \<0.001
                      Tumor necrosis factor   TNF-α      2.5                                    1969.39 ± 79.45                     0.048
  C3                  Interleukins            IL-5       20                                     543.54 ± 21.24                      0.019
                                              IL-6       5                                      2461.313 ± 1262.00                  \<0.001
                                              IL-12      20                                     80.01 ± 6.81                        0.030
                      Chemokines              IP-10      10                                     1278.39 ± 231.75                    0.043
                                              MCP-1      20                                     1030.51 ± 68.08                     \<0.001
                                              MIP-1α     20                                     2114.36 ± 370.80                    0.001
                      Growth factors          VEGF       20                                     1012.15 ± 326.24                    0.041
                      Tumor necrosis factor   TNF-α      20                                     248.90 ± 72.43                      \<0.001
  C4                  Interleukins            IL-5       10                                     884.12 ± 101.93                     0.004
                                              IL-6       5                                      3202.08 ± 979.88                    0.001
                                              IL-12      10                                     117.45 ± 31.74                      0.001
                      Chemokines              IP-10      10                                     1492.63 ± 83.89                     \<0.001
                                              MCP-1      20                                     1137.29 ± 185.70                    \<0.001
                                              MIP-1α     20                                     2037.31 ± 187.56                    \<0.001
                      Growth factors          VEGF       20                                     854.11 ± 156.70                     0.005
                      Tumor necrosis factor   TNF-α      20                                     167.52 ± 66.78                      \<0.001
  C5                  Interleukins            IL-5       5                                      1114.46 ± 29.83                     0.021
                                              IL-6       2.5                                    3648.16 ± 511.83                    \<0.001
                                              IL-12      10                                     147.88 ± 10.40                      0.005
                      Chemokines              IP-10      2.5                                    2265.18 ± 102.72                    \<0.001
                                              MCP-1      10                                     2517.43 ± 93.67                     \<0.001
                                              MIP-1α     20                                     8232.52 ± 898.63                    \<0.001
                      Growth factors          VEGF       20                                     1285.77 ± 86.27                     \<0.001
                      Tumor necrosis factor   TNF-α      10                                     1775.41 ± 63.58                     0.002
  C6                  Interleukins            IL-5       20                                     549.72 ± 36.72                      0.039
                                              IL-6       2.5                                    5123.25 ± 349.12                    0.001
                                              IL-12      5                                      177.77 ± 7.27                       0.001
                      Chemokines              IP-10      2.5                                    40,003.55 ± 450.70                  0.001
                                              MCP-1      10                                     2550.83 ± 224.64                    \<0.001
                                              MIP-1α     20                                     1977.30 ± 512.06                    \<0.001
                      Growth factors          VEGF       10                                     1945.85 ± 145.88                    0.001
                      Tumor necrosis factor   TNF-α      10                                     2019.75 ± 116.60                    0.001
  C7                  Interleukins            IL-5       20                                     648.54 ± 145.99                     \<0.001
                                              IL-6       5                                      5528.61 ± 1373.02                   0.025
                                              IL-12      5                                      184.23 ± 18.68                      0.006
                      Chemokines              IP-10      2.5                                    4866.26 ± 1112.07                   0.042
                                              MCP-1      5                                      2950.79 ± 216.11                    0.013
                                              MIP-1α     20                                     46,429.79 ± 57,254.80               0.003
                      Growth factors          VEGF       20                                     3237.31 ± 533.89                    0.028
                      Tumor necrosis factor   TNF-α      20                                     498.53 ± 49.62                      \<0.001
  C8                  Interleukins            IL-5       10                                     1145.75 ± 44.02                     0.003
                                              IL-6       10                                     2768.47 ± 251.34                    0.010
                                              IL-12      20                                     91.44 ± 4.78                        0.047
                      Chemokines              IP-10      5                                      3542.57 ± 23.92                     0.042
                                              MCP-1      5                                      4698.25 ± 496.07                    0.038
                                              MIP-1α     20                                     3388.37 ± 747.96                    0.036
                      Growth factors          VEGF       20                                     1279.67 ± 96.17                     0.024
                      Tumor necrosis factor   TNF-α      20                                     214.95 ± 17.30                      \<0.001
  C9                  Interleukins            IL-5       10                                     1053.83 ± 52.70                     \<0.001
                                              IL-6       2.5                                    5078.52 ± 188.87                    \<0.001
                                              IL-12      5                                      178.15 ± 6.58                       0.047
                      Chemokines              IP-10      10                                     2153.12 ± 276.80                    0.044
                                              MCP-1      5                                      3403.97 ± 357.54                    0.008
                                              MIP-1α     20                                     2841.48 ± 547.03                    \<0.001
                      Growth factors          VEGF       20                                     1582.33 ± 56.27                     \<0.001
                      Tumor necrosis factor   TNF-α      2.5                                    2357.16 ± 88.24                     \<0.001
  C10                 Interleukins            IL-5       20                                     638.38 ± 31.08                      \<0.001
                                              IL-6       5                                      5528.61 ± 1373.01                   0.038
                                              IL-12      20                                     104.41 ± 6.70                       \<0.001
                      Chemokines              IP-10      5                                      7768.87 ± 2750.43                   \<0.001
                                              MCP-1      10                                     2614.74 ± 177.56                    0.001
                                              MIP-1α     20                                     27,647.41 ± 5080.00                 0.000
                      Tumor necrosis factor   TNF-α      20                                     634.19 ± 22.88                      \<0.001
  C11                 Interleukins            IL-5       10                                     1037.19 ± 195.45                    0.022
                                              IL-6       5                                      4666.14 ± 272.45                    0.002
                                              IL-12      20                                     100.31 ± 3.70                       0.007
                      Chemokines              IP-10      5                                      1798.974 ± 549.03                   \<0.001
                                              MCP-1      5                                      4975.74 ± 426.89                    0.043
                                              MIP-1α     20                                     2790.32 ± 804.59                    \<0.001
                      Growth factors          VEGF       20                                     1612.03 ± 168.47                    0.002
                      Tumor necrosis factor   TNF-α      20                                     286.30 ± 48.72                      \<0.001
  C12                 Interleukins            IL-5       20                                     475.36 ± 25.89                      \<0.001
                                              IL-6       10                                     2659.19 ± 134.47                    0.004
                                              IL-12      20                                     74.18 ± 6.83                        0.001
                      Chemokines              IP-10      5                                      1867.55 ± 101.76                    0.002
                                              MCP-1      10                                     2148.69 ± 139.00                    0.042
                                              MIP-1α     20                                     2176.66 ± 383.20                    \<0.001
                      Growth factors          VEGF       20                                     1306.18 ± 67.25                     0.026
                      Tumor necrosis factor   TNF-α      10                                     1614.70 ± 66.95                     0.037

CSC: cigarette smoke condensate; SD: standard deviation; IL: interleukin; IP-10: induced protein 10; MCP-1: monocyte chemoattractant protein 1; MIP-1α: macrophage inflammatory protein 1α; TNF-α: tumor necrosis factor α; VEGF: vascular endothelial growth factor.

Cytokine profiling of lower limits of detection with CSC treatment {#section12-0394632017716370}
------------------------------------------------------------------

Lower limits of detection for 12 brands of CSC were IL-6 and IP-10, which were significantly reduced compared with the control group (⩽10 µg/mL). For CSC from all 12 brands, relatively low amounts (5--20 µg/mL) of IL-5, IL-12, and MCP-1 were detected. In contrast, the lower limits of detection for VEGF, MIP-1α, and TNF-α were not very sensitive (⩾20 µg/mL). The results are shown in [Table 3](#table3-0394632017716370){ref-type="table"}.

Discussion {#section13-0394632017716370}
==========

Several studies have demonstrated that macrophages from smokers are functionally impaired and secrete significantly lower levels of cytokines.^[@bibr9-0394632017716370]^ However, the impact of CSC exposure on macrophage cytokine secretion in vitro is not known. To investigate the general characteristics of the immunomodulatory effects of cigarette smoke, we used Luminex technology to assess the secretion of 20 cytokines from Ana-1 cells exposed to CSC from 12 brands of cigarettes. The results demonstrated that 8 of the 20 cytokines measured were secreted at significantly lower levels after exposure to CSC from 12 brands of cigarettes.

Our data showed that CSC differentially induced cytotoxicity. It has been demonstrated that cigarette smoke extract not only decreased cell viability but also induced apoptosis of Ana-1 cells.^[@bibr6-0394632017716370]^ Previous studies have also shown that exposure of human umbilical vein endothelial cells (HUVECs) to cigarette smoke extract led to phase cell cycle arrest.^[@bibr10-0394632017716370]^

Our study shows that CSC induced reduction in release of several cytokines, such as IL-5, IL-6, IL-12, TNF-α, IP-10, MCP-1, MIP-1α, and VEGF. The affected cytokines constitute two major subtypes: proinflammatory cytokines, including IL-5, IL-6, IL-12, TNF-α, and VEGF, and chemotactic cytokines, including IP-10, MCP-1, and MIP-1α. These subtypes are both known to play an important role in the immune response to infections. In light of our results, changes in the expression of these cytokines might explain, at least in part, the delayed wound repair process, increased susceptibility to infections, and relative resistance to some inflammatory diseases observed in smokers.^[@bibr11-0394632017716370]^ The effects on cytokines observed in this study can be supported by other studies.^[@bibr12-0394632017716370],[@bibr13-0394632017716370]^

In this report, lower limits of detection with CSC exposure showed that IL-6 and IP-10 were reduced significantly compared with the control group in a dose-dependent manner in Ana-1 cells treated with the majority of CSC. Specifically, 5 µg/mL CSC did not affect cell viability but significantly induced the secretion of these cytokines. In contrast, VEGF, MIP-1α, and TNF-α were not sensitive to CSC. Indeed, 20 µg/mL CSC significantly reduced the secretion of some cytokines. For example, IL-5, IL-12, and MCP-1 had distinct lower limits of detection. These phenomena indicate that the diverse components of cigarette smoke may impact its immunomodulatory effects in Ana-1 cells.

Limitation {#section14-0394632017716370}
==========

We do only tested one mouse macrophage for viability and cytokine production. This is the limitation of our study. We learned that the Ana-1 cell has been used to assess toxicological effects due to cigarette smoke. So, Ana-1 was selected in this study. In the further work, we will test CSC's effects in primary macrophage for viability and cytokine production.
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